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The worldwide funding devoted to nanotech-
nology research and development by govern-
ments, industry, and venture capitalists was
estimated to be around US$9.6 billion in
2005 (Lux Research Inc. 2006). A large por-
tion of this spending is still being allocated to
the development of nanoparticulate materials
because of their many novel physical and
chemical properties raising high expectations
for a variety of applications. One of these new
materials is carbon nanotubes (CNTs), which
have commercial expectations in different
manufacturing sectors. 
However, epidemiologic studies of air
pollution suggest that particulate matter has a
strong association with cardiopulmonary dis-
eases (Pope et al. 2004). Research has shown
that nanoparticles may enter the human body
more easily and be more biologically active
because of their larger surface area per mass
unit compared with that of larger particles
(Oberdörster G et al. 2005). The prospective
widespread use of engineered nanoparticles in
consumer products may increase environ-
mental, occupational, and public exposures
dramatically. Consequently, different stake-
holders have raised serious concerns regarding
health effects of engineered nanoparticles
(Helland et al. 2006). Recent review articles
on the toxicity potential of nanoparticles (Nel
et al. 2006; Oberdörster G et al. 2005) con-
clude that the toxicity of nanoparticles
depends on speciﬁc physiochemical and envi-
ronmental factors. Thus, the toxic potential
of each type of nanoparticle has to be evalu-
ated individually. 
Here we review the currently available lit-
erature on the potential risks of CNTs to
human health and the environment. We also
investigated the life cycle of CNTs, as release
into different environmental compartments
may occur at the production stages as well as
at the product’s use and disposal stages, which
may directly or indirectly lead to human expo-
sure. However, the published literature
revealed many unanswered questions.
Therefore, we also systematically interviewed
seven leading world-class scientists and inte-
grated their contemporary knowledge into this
review (see Supplemental Material; http://
www.ehponline.org/docs/2007/9652/suppl.
pdf). This assisted us in identifying questions
and developing recommendations. The scien-
tists interviewed were key authors or project
leaders who have investigated and reported the
potential impacts of CNTs on human health
or environment. Through this combined
approach we are able to present an updated
and contemporary knowledge base for
scientiﬁc discussion.
In this review, we use the term “carbon
nanotubes” when addressing the general
aspects of the material, which includes single-
walled carbon nanotubes (SWCNTs) and
multiwalled carbon nanotubes (MWCNTs).
Here “multi” is deﬁned as two or more walls.
The terms “SWCNTs” and “MWCNTs” are
used in a speciﬁed manner.
Exposure to Carbon Nanotube
Material
Exposure in occupational settings. Procedures
for the handling of CNTs can result in
aerosol release of these materials into the sur-
roundings (Maynard et al. 2004). MWCNT
aerosols generally have diameters between
20 nm to > 200 nm, lengths from 1,000 nm
to > 106 nm, and different shapes (straight,
partly rigid, bent, curled, and partly ﬂexible)
that may appear single or in clumps or ropes
(Donaldson et al. 2006).
Only one published study has investigated
the potential for SWCNTs to become air-
borne. A laboratory study by Maynard et al.
(2004) investigating the physical nature of
the aerosol formed during mechanical agita-
tion was complemented by a field study of
SWCNT release during handling of unreﬁned
SWCNTs. The authors found that sufﬁcient
agitation of unreﬁned SWCNT material can
release ﬁne particles into the air, but the con-
centrations generated while handling the mate-
rial in the field were very low (< 53 μg/m3).
The laboratory study also revealed that differ-
ent SWCNT production methods produced
different types of aerosols. The laser ablation
process generated a more compact aerosol
that was difﬁcult to break down into smaller
particles, whereas the HiPCO (high-pressure
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Carbon nanotubes (CNTs) are considered one of the most promising materials in nanotechnology,
with attractive properties for many technologic applications. The different synthesis, purification,
and postprocessing methods produce CNTs with different physical characteristics, which can be
applied in different fields ranging from composite materials, medical applications, and electronics
to energy storage. The widespread projected use of CNTs makes it important to understand their
potential harmful effects. In this environmental health review we observed a remarkable range of
results of some of the toxicology studies. The comparability should be improved by further stan-
dardization and introduction of reference materials. However, at present the findings of this review
suggest several key points: a) there are different types of CNTs, and therefore they cannot be con-
sidered a uniform group of substances; and b) in environmental compartments, CNTs can be
bioavailable to organisms. The properties of CNTs suggest a possible accumulation along the food
chain and high persistence. In organisms the absorption, distribution, metabolism, excretion, and
toxicity of CNTs depend on the inherent physical and chemical characteristics such as CNT func-
tionalization, coating, length, and agglomeration state that are influenced by the external environ-
mental conditions during CNT production, use, and disposal stages. Characterized exposure
scenarios could therefore be useful when conducting toxicologic studies. However, CNTs produce a
toxic response upon reaching the lungs in sufficient quantity; this reaction is produced in a time-
and dose-dependent manner. The identification of possible risks to human health and environment
is a prerequisite for a successful introduction of CNTs in future applications. Key words: carbon
nanotubes, cytotoxicology, ecotoxicology, environment, environmental fate, human health, in vitro,
in vivo, nanomaterials, nanotechnology, nanotoxicology. Environ Health Perspect 115:1125–1131
(2007). doi:10.1289/ehp.9652 available via http://dx.doi.org/ [Online 10 May 2007]
carbon monoxide) process generated a more
extended material that was easier to break
down into smaller particles and appeared to
lead to higher airborne concentrations. 
Maynard et al. (2004) also found glove
deposits of SWCNTs during handling that
were estimated at between 0.2 and 6 mg per
hand and thus concluded that large SWCNT-
containing clumps had the propensity to
become airborne and could remain so for long
periods. This may cause dermal exposure and
health risks even in less well-protected areas.
Maynard et al. (2004) noted that production
volume was very small (research facility) and
that workers took great care to reduce product
loss during handling of the material. However,
CNTs contain catalyst metals such as nickel,
which is associated with increased risks of can-
cer in the nose region (Feron et al. 2002).
Cleaning operations can also lead to emis-
sions. The cleaning of the production cham-
bers is performed usually using solvents or
water, tissues, brushes, and sponges that are
discarded after cleaning (VDI 2004). This
waste carries CNTs into the waste stream,
thereby possibly becoming a source of release
into the environment. 
Exposure through environmental media.
Exposure through environmental media is
highly relevant for several reasons: a) The wide-
spread applications envisioned for CNTs may
lead to substantial production volumes, and
consequently to increased emissions into the
environmental compartments air, groundwater,
and soil. b) The physical and chemical processes
in the environmental compartments may alter
the properties of CNTs, for example, abiotic
factors such as ultraviolet light may alter the
coatings of CNTs as observed with fullerenes
(Kamat et al. 1998) and quantum dots (Derfus
et al. 2004). Consequently, this may also
change the behavior of CNTs in the environ-
ment and thus inﬂuence their environmental
fate and impact. c) CNTs are possibly one of
the least biodegradable man-made materials
ever devised (Lam et al. 2004). They are totally
insoluble in water in pristine form (Lam et al.
2004) and are lipophilic by nature (Wu et al.
2006). It is generally known that biopersistent
and lipophilic chemicals may accumulate along
the food chain; therefore, such a scenario
should also be evaluated with CNTs.
In aqueous environments, SWCNTs
clump together to form aggregates in the
micrometer range; these aggregates do not
change in size distribution with increasing
salinity or temperature (Cheng and Cheng
2005). However, the aggregation differs with
pH changes in water (Cheng and Cheng 2005)
and postsynthesis treatment of the SWCNTs
with, for example, acid or surfactants (Chen
et al. 2004). Both these studies found that pris-
tine nanotubes formed stable aggregates,
whereas acid-treated nanotube suspension
showed greater dispersion variability over time,
yielding looser structures at large-length scales
and more compact structures at small-length
scales. The addition of a surfactant to CNTs
resulted in a hydrophilic interface at the tip of
the nanotubes that signiﬁcantly enhanced nan-
otube dispersion. In laboratory assessments
designed to assess the potential migration in
natural porous media, SWCNTs have been
shown to have mobility and deposition behav-
iors different from those of other nanoparticles
(Lecoanet and Wiesner 2004; Lecoanet et al.
2004). SWCNTs functionalized to facilitate
dispersion in water displayed the highest
mobility together with water-soluble fullerol,
whereas colloidal C60, anatase titanium dioxide
(TiO2), and ferroxane were among the least
mobile of the nanomaterials evaluated. 
The large surface area of CNTs may cause
other molecules to adhere and potentially pick
up pollutants and transport these throughout
the environment (Kleiner and Hogan 2003).
Several studies have investigated different car-
bon nanomaterials as superior sorbents of
organic pollutants, metals, fluoride, and
radionuclide 243-americium [243Am(III)]
(Fiorito et al. 2006; Jia et al. 2005; Yang et al.
2006). Yang et al. (2006) found a high adsorp-
tion capacity of polycyclic aromatic hydrocar-
bons (PAHs) with different types of CNTs
(MW and SW). This finding indicates a
potential effect on the fate of PAHs upon their
release into the environment. The adsorption
capacity was found with the order SWCNTs >
MWCNTs > C60 and seemed to be related to
the surface area, micropore volume, and the
volume ratios of mesopore to micropore. 
Oberdörster et al. (2006), in a preliminary
study, investigated the ingestion of SWCNTs
by the suspension-feeding worm Caenorhabditis
elegans. SWCNTs moved through the digestive
tract and were not absorbed by the animal.
However, even if SWCNTs did stay in the
digestive tract, these materials could move up
the food chain, as these worms and other
organisms are consumed by benthivores.
SWCNTs have also been shown to be bioavail-
able to aquatic organisms, as both water-solubi-
lized (wrapped with a synthetic peptide) and
unsolubilized SWCNTs were detected in the
fecal material collected from the digestive tract
in the exposed ﬁsh (Oberdörster E et al. 2005).
For the water-solubilized SWCNT-exposed
ﬁsh, clumps of SWCNTs were also found on
the gill, but similar clumps were not visible in
unsolubilized SWCNT-exposed ﬁsh. However,
the ﬁsh mistook the unsolubilized SWCNTs
(floating on top of the water) for food and
ingested them (Oberdörster et al. 2006).
Furthermore, because pristine CNTs are
lipophilic, there is concern that they might be
taken up by microbial communities and roots
(Oberdörster et al. 2006) and, consequently,
accumulate in plant tissues. 
Carbonaceous nanoparticles, including
MWCNTs, can also be formed by natural
processes (Velasco-Santos et al. 2003) and
anthropogenic combustion processes (Murr
et al. 2004). Although these MWCNTs can
be prime suspects in the pathogenesis of car-
diopulmonary diseases induced by ﬁne partic-
ulate matter, there are physical differences
between combustion-generated and manufac-
tured MWCNTs (Lam et al. 2006). These
MWCNT structures may therefore be less
important when the impacts of engineered
CNTs are being assessed, as the studies to
date suggest that when the properties of
CNTs are altered by engineering, changes in
the environmental fate of and human expo-
sure to CNTs occur through the different
environmental media. 
Human Health
In vivo studies. Pulmonary toxicity. The ﬁrst
in vivo study of fullerene soot containing
CNTs did not find any inflammation in the
respiratory tract of guinea pigs or change of
pulmonary function 4 weeks after exposure
(Huczko et al. 2001), but it is possible that the
method applied in this study (not examining
lung pathology) did not reﬂect the actual toxic-
ity of the material. The followup study with
analysis 90 days postexposure of six different
types of MWCNTs administered in individual
doses (12.5 mg) to guinea pigs found small dif-
ferences between the types of MWCNTs
(Grubek-Jaworska et al. 2006; Huczko et al.
2005). However, for all types of MWCNTs
there were multifocal granulomas observed
around the materials, inﬂammatory reactions
of terminal and respiratory bronchioles, and in
some animals, mild ﬁbrosis in alveolar septa. 
SWCNT soot generated by the laser abla-
tion method and intratracheally instilled in
rats produced transient inflammation, cell
injury effects, and a subsequent non-dose-
dependent series of multifocal granulomas
(Warheit et al. 2004). In comparison, equal
doses of quartz produced sustained pulmonary
inflammation, cytotoxicity, and fibrosis in a
dose-dependent fashion. The authors ques-
tioned whether the failed observation of a
dose-dependent relationship between SWCNT
exposure and formation of the granulomas
could be the result of the method of instilla-
tion and suggested that it should be clariﬁed
in an inhalation toxicity study.
In an intratracheal instillation study of
mice, three types of SWCNTs were investi-
gated (Lam et al. 2004)—two types made by
the HiPCO method and one by the electric arc
method. The results from all three types
showed that regardless of the amount of metal
impurities, dose-dependent lung lesions were
characterized chieﬂy by interstitial granulomas.
The study also showed that both SWCNTs
and ultrafine carbon black were taken up by
Helland et al.
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alveolar macrophages, but that the effects of
these materials were different. Macrophages
containing carbon black were homogeneously
distributed over the alveolar space, but
macrophages containing SWCNTs clustered
to form granulomas in centrilobular locations.
In comparison, quartz induced mild to
moderate pulmonary inflammation, which
was considered less severe than that induced
with SWCNTs.
The consequent agglomeration of CNTs
into nanoropes (Tagmatarchis and Prato 2004)
makes it difﬁcult to manipulate and administer
these particles to experimental animals without
forming nonrespirable particles that can lead to
mechanical blockage of the airways, as observed
in other studies (Grubek-Jaworska et al. 2006;
Warheit et al. 2004). Therefore, Muller et al.
(2005) compared the pulmonary toxicity of
ground and unground MWCNTs in rats, using
asbestos (Rhodesian chrysotile) and carbon
black as references. The length of the individual
MWCNT was reduced from 5.9 to 0.7 μm as a
result of the grinding procedure. The distribu-
tion in the lungs after intratracheal instillation
was different for the two types. Agglomerates of
intact MWCNTs remained in the largest air-
ways, whereas ground MWCNTs were much
better dispersed on the lung tissue surface.
Regarding toxicity, the study found that after
60 days there were indications of a higher
degree of pulmonary inflammation with
ground MWCNTs than that found with intact
MWCNT-treated animals. The induced effects
were dose dependent [bronchoalveolar lavage
fluid (BALF) lactate dehydrogenase (LDH)
activity and protein content]. Histologic and
biochemical analyses demonstrated a ﬁbrotic
reaction (granulomas) in the bronchi with
unground MWCNTs and in the alveolar space
or interstitial tissue with ground MWCNTs. In
summary, the ﬁndings of Muller et al. (2005)
indicate that asbestos-ground MWCNTs and
unground MWCNTs induce at least partially
similar effects [inﬂammation, ﬁbrotic reaction,
and increased tumor necrosis factor (TNF)-α
production], whereas carbon black showed a
transient inﬂammation with elevated TNF-α.
The authors therefore concluded that these data
point to a speciﬁc toxicity related to the unique
properties of CNTs.
In a pharyngeal aspiration study of mice by
Shvedova et al. (2005), the effects of HiPCO-
produced SWCNTs puriﬁed to a carbon con-
tent > 99% were investigated. The SWCNT
aggregate depositions were correlated with
granulomatous inﬂammation, whereas intersti-
tial ﬁbrosis with alveolar wall thickening was
observed to be greater at 60 days than at
28 days postexposure in lung regions distant
from the SWCNT aggregates. SWCNTs were
compared with equal doses of nanoparticulated
carbon black and ﬁne crystalline silica, which
did not induce granulomas and alveolar wall
thickening and caused signiﬁcantly less inﬂam-
mation. Furthermore, the authors investigated
whether exposure caused damage to pul-
monary cells. This was confirmed by an
increased number of alveolar type II cells
(type II cells replicate after alveolar type I cell
death). Exposure to SWCNTs also resulted in
accumulation of an oxidative stress biomarker
(4-hydroxynonenal) 1 day after exposure and
also in a time- and dose-dependent depletion
of a major antioxidant, glutathione, which was
most severe 1 day postexposure. The rapid and
dose-dependent ﬁbrogenic response in regions
of the lungs distant from SWCNT aggregates
and in the absence of persistent inﬂammation
was a unique ﬁnding in this study. 
Initially, Shvedova et al. (2005) associated
the interstitial ﬁbrosis with deposition of dis-
persed SWCNT structures and pointed out
that the mechanism for this response differs
from the classic ﬁbrogenic particle response in
that it is not driven by chronic inﬂammation
and chronic activation of alveolar macro-
phages. Additionally, the authors found that if
pathogenic bacteria were inhaled by mice in
combination with SWCNTs, bacterial clear-
ance from the lungs was signiﬁcantly slower.
This indicates that SWCNTs, in addition to
their primary effects, may also diminish general
resistance to pathogenic attacks.
Dermal toxicity. There is only one pub-
lished study in vivo on the dermal toxicity of
fullerene soot containing CNTs (Huczko and
Lange 2001). Forty volunteers were subjected
to a patch test, and four albino rabbits were
subjected to an eye test. The study found no
evidence of the induction of any response;
thus, the authors concluded that soot contain-
ing CNTs is not associated with any risks
(Huczko and Lange 2001). However, infor-
mation is insufﬁcient on CNT material char-
acterization and the study design for adequate
validation of these results.
Translocation. There are some contradic-
tory ﬁndings on the kinetics of water-soluble
functionalized and radioactively labeled CNTs
in the body. Wang et al. (2004) showed that
when hydroxylated SWCNTs with radioactive
iodine-125 atoms were injected into mice, the
SWCNTs behaved like small molecules,
passed easily through a number of compart-
ments, accumulated especially in bone, and
were distributed throughout the whole mouse
body except the brain. Eighty percent of the
total dosing of the SWCNTs was excreted by
the feces and urine after 11 days. In contrast,
Singh et al. (2006) found no accumulation of
chelated diethylentriaminepentaacetic and
indium-111-labeled SWCNTs or MWCNTs
in mice after 24 hr. The biological behavior of
functionalized (f)-CNTs is therefore compara-
ble to small molecules. They are removed
from the blood through the renal excretion
route. No toxic side effects or mortalities were
observed, and the excreted f-SWCNTs and
f-MWCNTs were intact (Singh et al. 2006).
Both studies are valid only for functionalized
tubes and cannot be interpolated for nonfunc-
tionalized tubes because of their hydrophobic
nature. The difference in the distribution in
bone is probably because the functionalization
of the tubes was not the same, which inﬂuenced
behavior in the organism. 
Histopathologic analysis ex vivo. Sato
et al. (2005) investigated the inﬂuence of dif-
ferent MWCNT lengths on the cytotoxicity of
MWCNTs in the human THP-1 leukemia
cell line in vitro and in subcutaneous tissue of
rat in vivo. In a long-term assay in vivo, the
authors observed 4 weeks after surgery that an
increased inflammatory response was estab-
lished only by the 825-nm MWCNTs, as
indicated by the formation of granulation tis-
sue. Most of the 220-nm MWCNTs were
observed in phagocytes, with many of these
recognizable in lysosomes. Conversely, the
825-nm MWCNTs were also observed in the
intercellular space. 
In vitro studies. The methodology of how
the toxicity of CNTs is evaluated depends
strongly on how CNTs are administered to
the cells (i.e., homogenously dispersed or not,
with or without surfactant, type and concen-
tration of the surfactant). Furthermore, CNTs
contain contaminants that may be bioactive
per se. Often the exact methodology and
CNT characteristics are not described, which
makes it difﬁcult to compare available data.
Pulmonary cytotoxicity. In an in vivo
study performed with nanoparticles such as
TiO2, Geiser et al. (2005) showed that these
particles could be taken up by the lung, passed
through the air-blood barrier, and translocated
into the bloodstream. This pathway cannot be
excluded for CNTs and may be supported at
the single-cell level. SWCNTs suspended in
Pluronic F108 (a nonionic surfactant) were
incorporated by peritoneal macrophage-like
cells using near-infrared fluorescence micro-
scopy. Cherukuri et al. (2004) found that
1.5 μg of 7.3 μg/mL SWCNTs were taken up
within 24 hr by macrophage cell cultures
grown in 24-well culture dishes. The fastest
reaction evoked by SWCNTs in macrophages
was an oxidative stress that occurred within
hours (Kagan et al. 2006). The improved
properties of nanomaterials also resulted in a
catalytic activity. This catalytic activity may
contribute to a new aggressive form of long-
term toxicity. Oxidative stress is an imbalance
between the production of reactive oxidizing
species (ROS) and their degradation by
antioxidants. The intracellular equilibrium
may be disturbed by the presence and/or
uptake of nanomaterials. The concentration of
ROS may be increased by the particle itself or
by the disturbance of the ROS degradation
pathway. Both cause an additional production
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of ROS, which interacts uncontrollably with
the cell membrane, DNA, and/or other cell
compounds, severely damaging these cell
compounds.
According to Muller et al. (2005) and as
described in previous sections, the adverse
effects of MWCNTs depend on the length of
the material used in vivo. Similar to their
in vivo study, the authors found that long
untreated tubes using Triton X-100 as the
vehicle evoked an LDH release of nearly 20%
at a concentration of 100 μg MWCNTs/one
24-well of a 24-well plate, whereas the short
ground MWCNTs induced a dose-dependent
LDH release up to 35% greater than the cor-
responding vehicle (Triton X-100) treatment.
This suggests that also in vitro the short
MWCNTs are more toxic than the long ones.
Interestingly, TNF-α was induced in vivo
(measured in BALF) as well as in vitro (meas-
ured in preactivated peritoneal macrophages),
indicating that TNF-α could be a reliable
marker for future in vitro studies.
A comparative in vitro cytotoxicity study of
several manufactured nanoparticles and nano-
tubes revealed that aggregated SWCNTs/
ropes, MWCNT raw material, and MWCNT-
aggregated tubes suspended in 5 μg/mL
dimethylsulfoxide (DMSO) affected cell viabil-
ity in murine lung alveolar macrophages at
nearly similar concentrations (Murr et al. 2005).
Compared with different oxide particles of dif-
fering quality such as aluminum oxide, zirco-
nium oxide, or ferric oxide, the SWCNTs and
MWCNTs expressed comparable median effec-
tive concentration (EC50) values (micrograms
per milligrams), which is analogous to the same
values obtained with asbestos used in the same
studies as reference material (Murr et al. 2005;
Soto et al. 2005). However, it is speculative to
generalize these results in terms of health risks to
humans, as the presented comparison study is
based only on short-term effects during a 48-hr
period. The physiologic relevance of these
results remains to be determined. 
In addition to the size, shape, and novel
physical and chemical properties, the degree
and type of agglomeration are important fac-
tors in the cytotoxicologic assessment of
CNTs. Well-dispersed SWCNTs were less
cytotoxic than micrometer-sized agglomerates
of SWCNTs (Wick et al. 2007). To determine
which carbonaceous nanomaterials have the
most severe effect, comparison studies were
conducted with the same biological model sys-
tem. Jia et al. (2005) compared SWCNTs,
MWCNTs, and C60 fullerenes suspended in
cell culture medium and found that the cyto-
toxicity is apparently based on SWCNTs >
MWCNT > quartz > C60. Fiorito et al. (2006)
in a second study on murine and human
macrophages claimed that graphite had the
most severe effect, followed by SWCNTs and
C60 fullerenes. 
Dermal cytotoxicity. To emphasize the
dermal toxicity of CNTs, Monteiro-Riviere
et al. (2005) exposed human epidermal ker-
atinocytes to MWCNTs that were produced
without further puriﬁcation processes. These
particles were taken up by the keratinocytes
in vacuoles where MWCNTs retained their
structure, as demonstrated by transmission
electron microscopy analysis. The cell viabil-
ity parameters were reduced by 400 μg/mL
MWCNTs to as much as 20% after a 24-hr
exposure. The expression of interleukin
(IL)-8 was increased up to 6 times (400 μg
MWCNTs/mL) in a dose-dependent manner
after that period compared with the corre-
sponding control cell cultures (Monteiro-
Riviere et al. 2005).
A detailed characterization of the molecu-
lar mechanism evoked by exposure of human
skin fibroblast cells to 0.6 and 0.06 μg
MWCNTs/mL was evaluated by gene
microarray analysis. This analysis showed that
MWCNTs induced cell cycle arrest and
increased apoptosis and necrosis. Of the genes
evaluated, 216 genes changed their expression
levels after treatment with MWCNTs at
0.6 μg/mL. The most significant gene cate-
gories were Golgi vesicle transport, protein
metabolism, secretory pathway, fatty acid
biosynthesis G1/S transition of mitotic cell
cycle, and cell homeostasis. The fact that these
cellular processes were affected by the presence
of MWCNTs indicates that this stress has a
remarkable influence on cell performance
(Ding et al. 2005).
Shvedova et al. (2003) exposed human ker-
atinocytes to HiPCO-produced SWCNT
material containing 30% by weight of iron.
One of the ﬁrst reactions on SWCNT treat-
ment, which occurred 18 hr after incubation,
was an increased oxidative stress, as indicated
by the presence of free radicals. The decrease of
the total antioxidant reserve and the reduction
of vitamin E as well as the increase of the lipid
peroxidation products compared with the con-
trol cell culture support strongly the presence
and the damage of the oxidative stress within
the cell cultures. Shvedova et al. (2003)
claimed that this oxidative stress was the reason
for the reduced cell viability.
In contrast to the work presented previ-
ously in which CNTs were suspended by soni-
fication in the presence of a solvent or cell
culture medium, Sayes et al. (2006) functional-
ized puriﬁed SWCNTs before dispersing them
in the cell culture medium. They produced
SWCNT–phenyl–sulfate, SWCNT–phenyl–
sodium sulfate (SO3H), and six mixed
SWCNT–carbon–sulfate and SWCNT–
phenyl–SO3H samples with ratios of 18, 41,
and 80, respectively. According to the authors
only water-dispersible SWCNTs were of con-
siderable interest for biological applications.
The suspensions obtained were used to treat
human dermal ﬁbroblast cultures. The pristine
unmodified SWCNTs evoked a rate of 80%
cell death at a concentration of 20 μg/mL,
whereas functionalized SWCNT–phenyl–
SO3H induced < 5% cell death at a concentra-
tion of 2,000 μg/mL. Cytotoxicity was also
strongly dependent on the type of sidewall
groups: SWCNT–phenyl–SO3H was less toxic
than the SWCNT with –phenyl-(COOH)2
group. The general conclusion reached by
Sayes et al. (2006) was that an inverse relation-
ship exists between the toxic potential and the
degree of side wall functionalization. This is an
important issue for further applications of
CNTs in nanomedicine. The intensive skin
cell–CNT interaction studies emphasize that
penetration of CNTs is still not understood.
In vitro studies with neurons. Poly-
m-aminobenzene sulfonic acid and ethylenedi-
amine functionalized MWCNTs (MWCNT–
PABS; MWCNT–EN) coatings were used to
coat glass cover slips as substrates for neuronal
growth. To achieve this coating, the tubes were
suspended in water and glass cover slips were
coated with the suspension. After the water was
evaporated, hippocampal neurons were seeded
on the cover slips. After 3 days of incubation
the number of branches per neuron, total neu-
rite length, and the number of neurites per
neuron of the cultivated neurons were
increased on functionalized MWCNTs but
not on pristine MWCNTs. However, it must
be noted that the performance of the neurons
grown on polyethyleneimine (positive control)
was better than that of neurons grown on
MWCNT-coated surfaces. Additionally, Hu
et al. (2004) claimed that the surface charge of
the modiﬁed MWCNT can be used to control
neurite outgrowth. An increase in neuronal
outgrowth and branching was achieved by the
functionalization of SWCNTs with polyethyl-
eneimine (SWCNT–PEI) compared with the
modified MWCNTs (Hu et al. 2005). The
authors described the morphology of these
nerve cells in detail, but the functional proof,
namely, in how far these cells exhibited sponta-
neous action potential and/or were able to be
stimulated, is still lacking. All these studies
reﬂected a positive effect of SWCNTs on neu-
rons, but compared with other cytotoxicologic
assessments, these tubes were immobilized on
glass. A similar study was conducted by Liopo
et al. (2006), who assessed growth and attach-
ment of the neuroblastoma glioma NG108, a
model neuronal cell, on unmodiﬁed SWCNT
substrates and/or substrates from SWCNTs
modified with 4-benzoic acid or 4-tert-
butylphenyl functional groups using a simple
functionalization method. Liopo et al. (2006)
found that SWCNT ﬁlms support cell growth
but at a reduced level compared with that of
tissue culture–treated polystyrene. 
Therefore, all studies mentioned here
investigated in principle the degree to which
Helland et al.
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nanostructured surfaces with chemical charac-
teristics of CNTs affect the outgrowth of nerve
cells and not the toxicity of suspended CNTs.
In vitro cytotoxicity studies in different
cell types. For human embryo kidney
(HEK293) cells it was reported that in 0.5%
DMSO, suspended SWCNTs are able to
inhibit cell proliferation and to decrease cell
adhesive ability in a dose- and time-dependent
manner (Cui et al. 2005). Additionally, these
HEK293 cells exhibit an active response to
SWCNTs such as the secretion of a 20- to
30-kDa protein with unknown function. After
SWCNT treatment, further observations were
made that were analogous to those in the
reports in the previous sections. These included
observations on cell cycle arrest in the G1 phase,
up- or down-regulation of cell cycle–associated
genes, and formation of apoptosis/necrosis. The
degree to which the presence of the DMSO
affects the cell surface and cell performance is
unclear in the present study.
As described previously, the surface chem-
istry strongly affects the toxic potential of
CNTs. For example, the cell viability of human
T lymphocytes was decreased to 80% by
exposure to 400 μg/mL of oxidized MWCNTs
(oxidized by reﬂuxing the MWCNTs in con-
centrated nitric acid). The reduction in cell via-
bility was explained by the increase of apoptotic
cells after the treatment (Bottini et al. 2006). In
comparison pristine MWCNTs reduced viabil-
ity by up to 40% and carbon black by only
15% at the same concentration. Interestingly,
the oxidized MWCNTs appeared to be shorter
and straighter.
Several studies were conducted in which
SWCNTs were modified by adding various
biological molecules such as phospholipids
conjugated with polyethylene glycol
(PEG)–folic acid, PEG–NH2, PEG–S–S-
DNA, etc. (Kam et al. 2004, 2005a, 2005b).
In all the studies the water dispersibility
increased and the tubes were incorporated in
HL60 and HeLa cells. Depending on the
modification of the SWCNTs, these tubes
could act as multifunctional biological trans-
porters, for example, DNA or siRNA (Bianco
2004; Bianco et al. 2005; Pantarotto et al.
2004). Unfortunately, no quantitative mea-
surement was performed to allow a statement
and comparison of these modiﬁed SWCNTs
regarding the uptake rate and induced toxicity.
Carbon nanotubes have also been proposed
by Price et al. (2004) as a possible new ortho-
pedic/dental implant surface material because
of their unique mechanical, electrical, and
cytocompatibility properties. Cell viability and
number of human osteoblast CRL-11372 were
determined after 3, 6, 11, and 24 hr of incuba-
tion by ethidium homodimer and calcein AM
staining. The authors used conventional ﬁbers
(diameter > 100 nm) and nanoscaled fibers
(diameter < 100 nm). The ﬁbers agglomerated
within 1 week in cell culture media to ropes of
about 340 nm in diameter in the case of con-
ventional ﬁbers and about 670 nm in the case
of nanoscaled fibers. The nanoscaled carbon
ﬁbers appeared to inﬂuence osteoblast viability
less than their conventional dimensioned
counterparts. The suspended carbon fiber
agglomerates were taken up by the osteoblasts
and were incorporated in lysosomal vacuoles
(Price et al. 2004). This future application of
carbon nanotubes as implant material is in
itself a promising issue, but one of the key
questions is do carbon nanotubes inﬂuence the
differentiation of osteoblast progenitor cells
and to what degree is the formation and activa-
tion of osteoblasts affected?
In conclusion, CNTs were taken up by
different cell types and evoked diverse effects
in the cells. A ﬁrst and fast reaction is the for-
mation of free radicals (oxidative stress), which
has been suggested as a key factor in further
cell reactions [e.g., Nel et al. (2006)]. Several
cell biological effects and changes in gene
expression patterns were described, but
because of the different CNT material and
suspension procedures used, quantitative and
comparison statements on the cytotoxicity of
CNTs in different cell types and tissue are
nearly impossible. Focused studies on inhala-
tion exposures are needed to evaluate in vitro
studies on their reliability and to build up the
epidemiologic databases.
Discussion
In the present review, we have investigated the
state of knowledge regarding the impact of
CNTs on human health and the environment.
At the time of the review, there were approxi-
mately 50 studies focusing on the effects of
CNTs on human health and environment,
with the majority of them in vitro studies
(Supplemental Material, Tables S4 and S5;
http://www.ehponline.org/docs/2007/9652/
suppl.pdf). Environmental impacts in particu-
lar have been investigated poorly. One of the
ﬁndings of the expert interviews was that the
current impact assessments have been con-
ducted without any overall research strategy
(Supplemental Material). Acknowledging this,
the experts have called for a better coordination
of research, which could provide interdiscipli-
nary and complementary results. 
There are different types of CNTs pro-
duced in and applied to products with a vari-
ety of physical and chemical properties and
potential exposure routes. The knowledge base
suggests that altering these properties induces
different effects on environmental health.
Additionally, these properties may change
during the life cycle of a product containing
CNTs, as external physical and chemical inﬂu-
ences differ at each stage. Therefore CNTs
may cause different environmental health
effects depending on the life cycle of the prod-
uct and fate of the product in the environ-
ment. Tracing the fate of CNTs from each
stage of the CNT product life cycle, as illus-
trated in Figure 1, may be an effective orienta-
tion for prioritizing research.
CNT material. The particular properties
of CNTs depend on the particular produc-
tion process used (Supplemental Material;
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Figure 1. The life cycle and environmental fate of CNTs. CNTs may change properties during the life cycle
of the product and in the environmental compartments. Humans and biota may therefore be exposed to
different types of CNTs.
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http://www.ehponline.org/docs/2007/9652/
suppl.pdf). After synthesis the raw material
contains nanoparticulate impurities that inﬂu-
ence the toxicity of the species. Postsynthesis
treatment alters various properties of CNTs
such as length, purity, degree of aggregation,
wall structure (doping), and surface functional-
ization. These properties are thought to deter-
mine toxicologic-relevant factors such as
particle size, mobility in the environment,
chemical reactivity, persistence, and bioavail-
ability. Hence, the impacts of engineered
CNTs are likely to differ from those of natu-
rally occurring CNTs and may additionally
depend on the technical application and cir-
cumstances of release.
Exposure. Emissions of CNTs may,
depending on the application, occur at all
stages in the product life cycle: synthesis, pro-
duction of intermediates, further processing,
product use, and disposal. From the produc-
tion sites, emission of CNTs into surrounding
air depends on process control, handling pro-
cedures (yielding, bottling, packing), cleaning,
safety installations and procedures (in case of
leakages and accidents), and waste condition-
ing. These procedures may also lead to release
of CNTs into the wastewater. Waste items
such as contaminated hand gloves, packaging,
or worn filter pads could disperse CNTs in
cases of sufficient agitation. The CNTs
released from the different stages may show
very different characteristics such as length,
surface properties, attachments, and agglomer-
ation size. The variety of effects observed in
the studies seems to result from the character-
istics of the particular CNTs tested. It is there-
fore essential to scrutinize whether CNTs used
in these studies are of the same type as the
CNTs that organisms may be exposed to
under real environmental conditions. A critical
investigation of the types of exposures to
CNTs before using CNTs in studies seems
crucial for the information value of the study.
Therefore, focusing on characterized exposure
scenarios could be very useful when conduct-
ing toxicologic studies.
Environmental compartments. The fate of
CNTs in environmental compartments may
differ depending on their specific properties
such as surface chemistry, electrical properties,
and oxidative potential. Studies show that
functionalization and state of aggregation are
likely to inﬂuence the behavior in water and
soil. It would therefore be useful to characterize
the CNT type and form that could be released
into the environmental compartments to assess
the fate of CNTs. However, the physical and
chemical conditions of the different environ-
mental compartments (such as redox potential,
pH, temperature, ultraviolet light, or synergis-
tic effects with toxins) are also likely to alter the
properties of CNTs or their functional attach-
ments, and thus their environmental fate.
Other molecules or particles stick easily to the
surface of CNTs and may alter the the behav-
ior of CNTs. Consequently, pollutants may be
transported in the environmental compart-
ments. Therefore, the question arises as to
whether and to what extent it would be possi-
ble to foresee and control the effects caused 
by different CNT material properties in the
environment.
Environmental health end points. Once
CNTs are released into environmental com-
partments, preliminary studies have shown
CNTs to be bioavailable to different organisms
in addition to being biopersistent. One can
therefore not exclude the possibility that CNTs
may accumulate along the food chain. These
studies emphasize a further need to study eco-
toxicity as well as longer time-scale impacts
covering bioaccumulation, biopersistency, and
negative effects on reproduction. 
Once taken up by humans or other species,
CNTs may cause oxidative stress, inflamma-
tion, cell damage, adverse effects on cell perfor-
mance, and, in a long-term perspective,
pathological effects like granulomas, ﬁbrosis,
and wall thickening. These effects have been
observed time and dose dependently in the
majority of toxicology studies. 
However, a remarkable range of results
has been observed in toxicology studies
(Supplemental Material, Tables S4 and S5;
http://www.ehponline.org/docs/2007/9652/
suppl.pdf). Comparing these different studies
is difﬁcult because different CNT species and
cell model systems have been employed. An in-
depth characterization of the CNTs employed
is crucial for interpretation of cytotoxicologic
and toxicologic assessments. The contradic-
tions in some of the results obtained could also
originate from the types and degrees of
agglomeration of the CNTs. In addition, the
surfactants or surface coating may have a sig-
nificant influence on the CNT–cell interac-
tion, an effect that remained unaccounted for
in several studies.
Strategies to enhance the explanatory
power of future toxicology studies should com-
prise some standardization of the CNT mater-
ial, test procedures, and cell models/organisms
employed. To that end, experts recommended
using SWCNTs from arc discharge synthesis,
as these SWCNTs show relatively good purity
and structural uniformity (Supplemental
Material; http://www.ehponline.org/docs/
2007/9652/suppl.pdf). In addition, a set of
toxic equivalency factors (TEFs) would be use-
ful for comparing the toxicologic effects of dif-
ferent types of CNTs. TEFs have been
developed to compare the toxicity of substance
classes such as PAHs, which comprise a wide
range of compounds (Nisbet and LaGoy
1992). The establishment of TEFs for CNTs
would need to consider nanospeciﬁc properties
of the material (e.g., particle size, aspect ratio,
agglomeration state) and would require investi-
gation of mechanisms and dose–response
dependency on the cellular level. 
To what extent CNTs can enter the blood-
stream, for example, through the alveolar pas-
sage, and whether organisms are able to
eliminate pristine CNTs remain unexplained.
To date, no biodegradation mechanisms for
CNTs that support elimination from the
organism have been investigated. However,
agglomeration and immobilization of CNTs
within tissue have been observed, for example,
in lung tissue. Some studies have shown that
functionalization may, in addition to inﬂuenc-
ing CNT mobility, also inﬂuence the degree of
toxicity. Functionalization may therefore be a
key parameter for controlling the impact of
CNTs on human health and the environment.
The important considerations discussed
above combine different scientiﬁc disciplines
ranging from materials science to biology.
Integrating nanotoxicology with a life-cycle
perspective will therefore be a prerequisite for
the development of nanotechnology-based
applications in a safe and responsible manner. 
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